Lucigen Gets $226K SBIR Grant from NIH | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Wisconsin biotech firm Lucigen said on Monday it has received a $226,401 Small Business Innovation Research Phase I grant from the National Institutes of Health to develop genomic tools for use in discovering and characterizing new therapeutics from fungi.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.